Literature DB >> 6360103

Childhood acid maltase deficiency. A clinical, biochemical, and morphologic study of three patients.

T Matsuishi, M Yoshino, K Terasawa, I Nonaka.   

Abstract

Three children, including two siblings and a patient with sporadic glycogenosis type II (childhood form of acid maltase deficiency [AMD] ), were studied clinically, biochemically, and morphologically. In addition to a delay in developmental milestones and mild generalized muscle weakness, nasal vocalization and an electromyographic finding of abnormal insertion voltage, followed by pseudomyotonic discharge, were assumed to be characteristic diagnostic findings for the childhood form of AMD. Since the neutral maltase activity was highest in the muscle biopsy specimen from the patient with the least severe weakness, the enzyme may play a role in reducing muscle involvement. Selective type 2A fiber atrophy and type 2B fiber deficiency in the affected muscles were the common histochemical findings in this particular form of AMD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360103     DOI: 10.1001/archneur.1984.04050130053022

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

Review 1.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

2.  Elevation of transaminases as an early sign of late-onset glycogenosis type II.

Authors:  M T Di Fiore; R Manfredi; L Marri; A Zucchini; L Azzaroli; G Manfredi
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

3.  Enzyme replacement therapy in juvenile glycogenosis type II: a longitudinal study.

Authors:  Laura Deroma; Mattia Guerra; Annalisa Sechi; Giovanni Ciana; Giorgia Cisilino; Andrea Dardis; Bruno Bembi
Journal:  Eur J Pediatr       Date:  2014-01-07       Impact factor: 3.183

4.  Clinical diversity in glycogenosis type II. Biosynthesis and in situ localization of acid alpha-glucosidase in mutant fibroblasts.

Authors:  A J Reuser; M Kroos; R Willemsen; D Swallow; J M Tager; H Galjaard
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

5.  A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier.

Authors:  M Uchino; E Uyama; H Kawano; J Hokamaki; K Kugiyama; Y Murakami; H Yasue; M Ando
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  A histochemical and electron microscopic study of skeletal muscle in an adult case of Chédiak-Higashi syndrome.

Authors:  M Uchino; E Uyama; T Hirano; T Nakamura; T Fukushima; M Ando
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 7.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

8.  Efficacy of multidisciplinary approach in the treatment of two cases of nonclassical infantile glycogenosis type II.

Authors:  B Bembi; G Ciana; C Martini; A Benettoni; A Gombacci; M Deganuto; M G Pittis
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  Assessing metabolic profiles in human myoblasts from patients with late-onset Pompe disease.

Authors:  Peter Meinke; Sarah Limmer; Stefan Hintze; Benedikt Schoser
Journal:  Ann Transl Med       Date:  2019-07

10.  Uptake of moss-derived human recombinant GAA in Gaa -/- mice.

Authors:  Stefan Hintze; Paulina Dabrowska-Schlepp; Birgit Berg; Alexandra Graupner; Andreas Busch; Andreas Schaaf; Benedikt Schoser; Peter Meinke
Journal:  JIMD Rep       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.